Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome.
about
Database of T cell-defined human tumor antigens: the 2013 updateImmunoproteasomes: structure, function, and antigen presentationModelling proteasome and proteasome regulator activities.An antigenic peptide produced by reverse splicing and double asparagine deamidationEnzymatic amine acyl exchange in peptides on gold surfaces.The T210M Substitution in the HLA-a*02:01 gp100 Epitope Strongly Affects Overall Proteasomal Cleavage Site Usage and Antigen Processing.Towards a liquid self: how time, geography, and life experiences reshape the biological identity.Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes.Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex.A MAGE-C2 antigenic peptide processed by the immunoproteasome is recognized by cytolytic T cells isolated from a melanoma patient after successful immunotherapy.CD8(+) T cells of Listeria monocytogenes-infected mice recognize both linear and spliced proteasome products.Human Tumor Antigens and Cancer Immunotherapy.CD8+ T-cell auto-reactivity is dependent on the expression of the immunoproteasome subunit LMP7 in exposed to lipopolysaccharide antigen presenting cells and epithelial target cells.Peptide splicing by the proteasome.Shuffling peptides to create T-cell epitopes: does the immune system play cards?CD8 + T-cell responses in vaccination: reconsidering targets and function in the context of chronic antigen stimulation.Biological consequences of structural and functional proteasome diversity
P2860
Q27022422-2ACBB1C8-885C-403D-BA05-5C808CBD3D70Q27024527-5AC00895-97DF-4742-B927-BFB5380AF0A3Q33912642-1B0305E6-9094-46DF-9583-6A63C997B77FQ34192290-1E0655A9-7155-4DBD-B0F9-110E458F083EQ34481736-DFE233EA-26C2-48E4-B426-BA868F04862BQ36381923-5BD30C09-0A4A-4D47-AE0F-73CA17B7DBCFQ37705431-A9D0E4D8-AF30-44AF-A8D7-9558D2C775B0Q37851050-2D526441-4F8D-446F-9281-B7C265BC282DQ38269935-13634DAE-7B11-4D09-AE76-D7A234807A6FQ39612032-09508004-7085-4796-98B4-7D92B25DA397Q40779616-50EF8B3D-0F6C-41F9-A527-347C0487C6B4Q41533232-12FF938D-428E-4CFB-82F0-B5A644E49A63Q45325413-E6114F1B-AB27-4414-816F-7BFE333DB021Q47434235-5D4047C8-04C7-461F-B8FB-47684299549EQ49852764-C13E6A70-764F-4DD3-A3D5-9D4A21BACC4FQ54209283-2E546EF4-D2A3-491F-B791-C6721F0C35CAQ58700644-D59F95FC-3549-4EEA-AECE-CC227B703215
P2860
Differences in the production of spliced antigenic peptides by the standard proteasome and the immunoproteasome.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Differences in the production ...... some and the immunoproteasome.
@en
Differences in the production ...... some and the immunoproteasome.
@nl
type
label
Differences in the production ...... some and the immunoproteasome.
@en
Differences in the production ...... some and the immunoproteasome.
@nl
prefLabel
Differences in the production ...... some and the immunoproteasome.
@en
Differences in the production ...... some and the immunoproteasome.
@nl
P2093
P2860
P356
P1476
Differences in the production ...... some and the immunoproteasome.
@en
P2093
Alexandre Dalet
Benoît J Van den Eynde
Nathalie Vigneron
Vincent Stroobant
P2860
P356
10.1002/EJI.201040750
P407
P577
2010-12-09T00:00:00Z